Ceeto Capital Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.61M | Hold |
29,864
| – | – | 1.11% | 18 |
|
|
2025
Q4 | $3.17M | Hold |
29,864
| – | – | 0.92% | 21 |
|
|
2025
Q3 | $2.53M | Buy |
29,864
+3,514
| +13% | +$289K | 0.73% | 25 |
|
|
2025
Q2 | $2.1M | Buy |
26,350
+694
| +3% | +$55.2K | 0.73% | 27 |
|
|
2025
Q1 | $2.32M | Buy |
25,656
+1,000
| +4% | +$93.4K | 0.88% | 23 |
|
|
2024
Q4 | $2.47M | Buy |
24,656
+1,200
| +5% | +$124K | 0.91% | 20 |
|
|
2024
Q3 | $2.68M | Buy |
23,456
+200
| +0.9% | +$23.8K | 1% | 16 |
|
|
2024
Q2 | $2.89M | Hold |
23,256
| – | – | 1.12% | 15 |
|
|
2024
Q1 | $3.08M | Buy |
23,256
+3,000
| +15% | +$370K | 1.26% | 12 |
|
|
2023
Q4 | $2.22M | Hold |
20,256
| – | – | 0.95% | 23 |
|
|
2023
Q3 | $2.1M | Buy |
20,256
+400
| +2% | +$43.1K | 1.01% | 19 |
|
|
2023
Q2 | $2.3M | Hold |
19,856
| – | – | 1.05% | 15 |
|
|
2023
Q1 | $2.12M | Hold |
19,856
| – | – | 1.06% | 15 |
|
|
2022
Q4 | $2.21M | Buy |
19,856
+86
| +0.4% | +$8.79K | 1.22% | 12 |
|
|
2022
Q3 | $1.71M | Hold |
19,770
| – | – | 0.98% | 18 |
|
|
2022
Q2 | $1.82M | Sell |
19,770
-2,000
| -9% | -$177K | 0.99% | 19 |
|
|
2022
Q1 | $1.8M | Hold |
21,770
| – | – | 0.82% | 31 |
|
|
2021
Q4 | $1.68M | Buy |
21,770
+200
| +0.9% | +$15.9K | 0.7% | 36 |
|
|
2021
Q3 | $1.63M | Buy |
21,570
+7,000
| +48% | +$532K | 0.76% | 35 |
|
|
2021
Q2 | $1.14M | Sell |
14,570
-1,096
| -7% | -$81.5K | 0.51% | 55 |
|
|
2021
Q1 | $1.16M | Sell |
15,666
-104
| -0.7% | -$7.67K | 0.57% | 51 |
|
|
2020
Q4 | $1.24M | Sell |
15,770
-80
| -0.5% | -$6.12K | 0.62% | 46 |
|
|
2020
Q3 | $1.26M | Hold |
15,850
| – | – | 0.7% | 42 |
|
|
2020
Q2 | $1.17M | Hold |
15,850
| – | – | 0.76% | 43 |
|
|
2020
Q1 | $1.17M | Sell |
15,850
-4,844
| -23% | -$381K | 0.94% | 29 |
|
|
2019
Q4 | $1.8M | Sell |
20,694
-524
| -2% | -$43K | 1.18% | 16 |
|
|
2019
Q3 | $1.71M | Sell |
21,218
-925
| -4% | -$74.1K | 1.24% | 18 |
|
|
2019
Q2 | $1.78M | Hold |
22,143
| – | – | 1.31% | 17 |
|
|
2019
Q1 | $1.76M | Hold |
22,143
| – | – | 1.29% | 16 |
|
|
2018
Q4 | $1.62M | Hold |
22,143
| – | – | 1.34% | 16 |
|
|
2018
Q3 | $1.51M | Hold |
22,143
| – | – | 1.04% | 25 |
|
|
2018
Q2 | $1.29M | Sell |
22,143
-10,480
| -32% | -$591K | 0.97% | 28 |
|
|
2018
Q1 | $1.71M | Hold |
32,623
| – | – | 1.3% | 15 |
|
|
2017
Q4 | $1.77M | Hold |
32,623
| – | – | 1.26% | 17 |
|
|
2017
Q3 | $1.99M | Buy |
+32,623
| New | +$1.98M | 1.5% | 11 |
|
Other funds holding MRK
VCM
VPM
Ceeto Capital Group's MRK Position: Q1 2026 in Review
Ceeto Capital Group held its Merck (MRK) position steady in Q1 2026 at 29,864 shares worth $3.61M. The position accounts for 1.11% of the portfolio, ranked #18.
Ceeto Capital Group first reported a position in MRK in Q3 2017 and has held it in 35 quarters since. 3,776 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Ceeto Capital Group held 29,864 shares of Merck worth $3.61M as of Q1 2026.
- Ceeto Capital Group left its Merck share count unchanged in Q1 2026.
- Merck made up 1.11% of Ceeto Capital Group's portfolio in Q1 2026, its #18 holding.
- Ceeto Capital Group first reported a position in Merck in Q3 2017 and has held it in 35 quarters since.
- 3,776 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Ceeto Capital Group's 13F filing for Q1 2026, filed 14 May 2026.